Studies on the mechanism of action of 6-mercaptopurine. Interaction with copper and xanthine oxidase
- 28 February 1981
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 193 (3) , 799-803
- https://doi.org/10.1042/bj1930799
Abstract
Interaction between 6-mercaptopurine [an antineoplastic, immunosuppressive and antiinflammatory agent], Cu2+ and the enzyme xanthine oxidase (EC 1.2.3.2) was examined. Cu2+ inhibited the enzyme: 6-mercaptopurine protected and reversed the enzyme inhibition produced by the metal ion. The formation of a complex between 6-mercaptopurine and Cu2+ seems to be responsible for the observed effect. Job''s method showed the composition of the complex to be 1:1. The apparent stability constant (log K value), as determined by Subhrama Rao and Raghave Rao''s method was 6.74. The formation of a stable complex between 6-mercaptopurine molecules and Cu2+ may be an additional mechanism of action of 6-mercaptopurine, particularly with reference to its antiinflammatory properties [in vertebrates].This publication has 14 references indexed in Scilit:
- IMBALANCE OF PURINE METABOLISM IN HEPATOMAS OF DIFFERENT GROWTH-RATES AS EXPRESSED IN BEHAVIOR OF XANTHINE-OXIDASE (EC 1.2.3.2)1976
- Copper and Primary Biliary CirrhosisGastroenterology, 1974
- ANTI-INFLAMMATORY DRUGS AND TISSUE COPPERThe Lancet, 1974
- Serum copper observations in patients with malignant lymphomaCancer, 1973
- Studies on milk xanthine oxidase. Some spectral and kinetic properties.1969
- Serum copper levels in lymphoma and leukemia.Special reference to Hodgkin's diseaseCancer, 1968
- Treatment of Ulcerative Colitis with AntimetabolitesBMJ, 1966
- Chemical suppression of the immune response.1963
- Effect of 6-mercaptopurine on inflammation.1962
- The chemistry of xanthine oxidase. 4. The problems of enzyme inactivation and stabilizationBiochemical Journal, 1959